Finance

Lists
IKT:NASDAQ
Inhibikase Therapeutics Inc
US$2,02
-1,46%
(-0,030) 1D
US$2,06
+1,98% (+0,040)
After hours
Closed: 29 ກ.ຍ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IKT...
Open
US$2,03
High
US$2,05
Low
US$2,00
Mkt. cap
281,86 ລ້ານ
Avg. vol.
518,77 ພັນ
Volume
400,25 ພັນ
52-wk high
US$2,61
52-wk low
US$1,33
EPS
US$-0,44
Beta
0,95
Shares outstanding
139,54 ລ້ານ
No. of employees
35
Open
US$2,03
High
US$2,05
Low
US$2,00
Mkt. cap
281,86 ລ້ານ
Avg. vol.
518,77 ພັນ
Volume
400,25 ພັນ
52-wk high
US$2,61
52-wk low
US$1,33
EPS
US$-0,44
Beta
0,95
Shares outstanding
139,54 ລ້ານ
No. of employees
35
About Inhibikase Therapeutics Inc
CEO-
Employees35
Founded2008
HeadquartersWilmington, ເດລາແວ, ສະຫະລັດ
SectorBiotechnology
Analyst ratings
Based on 5 analysts giving stock ratings to IKT in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for IKT in the last 3 months.
Highest
Current US$2,02
US$8,00 (+296,04%)
Average
US$6,40 (+216,83%)
Lowest
US$5,00 (+147,52%)
Analyst
Recommendation
Action
Price target
Projected
Date
Gaurav Maini
LifeSci Capital
Buy
Maintained
US$5,00
+147,5%
09/15/2026
Jason McCarthy
Maxim Group
Buy
Maintained
US$8,00
+296%
08/13/2026
Mazahir Alimohamed
Oppenheimer
Buy
Maintained
US$5,00
+147,5%
08/12/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
US$8,00
+296%
07/31/2026
Jason Zemansky
Bank of America Securities
Buy
Maintained
US$6,00
+197%
07/27/2026
Olivia Brayer
Cantor Fitzgerald
Buy
Maintained
US$4,00
+98%
05/18/2026
Aydin Huseynov
Ladenburg Thalmann & Co.
Buy
Initiated
US$4,00
+98%
03/04/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
-
-
-
-
Cost of goods sold
7,65 ລ້ານ
-23,43 ລ້ານ
-
-
Cost of revenue
7,65 ລ້ານ
-23,43 ລ້ານ
-
-
Research and development expenses
-
22,39 ລ້ານ
10,84 ລ້ານ
13,39 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,61 ລ້ານ
6,77 ລ້ານ
7,38 ລ້ານ
7,66 ລ້ານ
Operating expense
5,61 ລ້ານ
29,17 ລ້ານ
18,22 ລ້ານ
21,05 ລ້ານ
Total operating expenses
13,26 ລ້ານ
5,73 ລ້ານ
18,22 ລ້ານ
21,05 ລ້ານ
Operating income
-13,26 ລ້ານ
-5,73 ລ້ານ
-18,22 ລ້ານ
-21,05 ລ້ານ
Other non operating income
-
-
1,46 ລ້ານ
1,46 ລ້ານ
EBT including unusual items
-11,93 ລ້ານ
-12,73 ລ້ານ
-16,38 ລ້ານ
-19,59 ລ້ານ
EBT excluding unusual items
-12,42 ລ້ານ
-4,69 ລ້ານ
-16,75 ລ້ານ
-19,59 ລ້ານ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-11,93 ລ້ານ
-12,73 ລ້ານ
-16,38 ລ້ານ
-19,59 ລ້ານ
Net profit margin
-
-
-
-
Earnings per share
-
-
-0,10
-0,11
Interest and investment income
838,09 ພັນ
1,04 ລ້ານ
-
-
Interest expense
-
-
-
-
Net interest expenses
838,09 ພັນ
1,04 ລ້ານ
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-13,24 ລ້ານ
-5,73 ລ້ານ
-18,20 ລ້ານ
-21,04 ລ້ານ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
ແອັບຂອງ Google